Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor-Associated Lymphatics Upregulate MHC-II to Suppress Tumor-Infiltrating Lymphocytes

International Journal of Molecular Sciences(2022)10.3390/ijms232113470Source: DataRank Database

Tumor-Associated Lymphatics Upregulate MHC-II to Suppress Tumor-Infiltrating Lymphocytes is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.21)OA: goldTopics (50)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Hyeung Ju Park ORCID,Jinyeon Shin ORCID,Jung Eun Baik ORCID,Babak J. Mehrara ORCID,Raghu P. Kataru ORCID

Live enrichment

PubMed:36362253 PMC:PMC9654328 OpenAlex:https://openalex.org/W4308211757

NIH/NCI Cancer Center

Grant: P30 CA008748

NIH/NCI Cancer Center

Grant: R01 HL111130

NIH/NCI Cancer Center

Grant: 691032

NIH/NCI Cancer Center

Grant: T32 CA009501

NIH HHS

Grant: HL111130

National Institutes of Health

Grant: 4R01HL111130-05

Mechanisms of fibrosis and lymphatic dysfunction in post-surgical lymphedema

National Institutes of Health

Grant: 5T32CA009501-22

SURGICAL ONCOLOGY RESEARCH TRAINING GRANT

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

FWCI

1.21

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/23/21/13470/pdf?version=1667888144

publisherhttps://www.mdpi.com/1422-0067/23/21/13470/pdf?version=1667888144

publisherhttps://www.mdpi.com/1422-0067/23/21/13470/pdf

journalhttps://doi.org/10.3390/ijms232113470

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36362253

Fields of Study

Lymphatic System and DiseasesAngiogenesis and VEGF in CancerLymphatic Disorders and Treatments0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHistocompatibility Antigens Class IIAntigens, NeoplasmHumansMelanomaMice, TransgenicCD4-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingAntigen PresentationCD8-Positive T-LymphocytesEndothelial CellsMiceTumor Microenvironment

Keywords

AntigenCD8MHC class ICytotoxic T cellTumor microenvironmentBiologyMajor histocompatibility complexAntigen-presenting cellAntigen presentationCancer researchCell biologyImmunologyTumor antigenT cellImmune systemIn vitroImmunotherapyTumor-infiltrating LymphocytesLymphatic ImmunomodulationCD4-Positive T-LymphocytesHistocompatibility Antigens Class IIEndothelial CellsMice, TransgenicCD8-Positive T-LymphocytesArticleMiceLymphocytes, Tumor-InfiltratingAntigens, NeoplasmHumansAnimalsMelanoma

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being